(RTTNews) - Nyxoah S.A. (NYXH) has announced the commercial launch of its Genio system in the Middle East, with the first successful implant performed at Saudi German Hospital in Dubai, UAE. Genio is ...
Nyxoah announces full-body 1.5T and 3T MRI compatibility for the Genio® system to treat Obstructive Sleep Apnea (OSA) Mont-Saint-Guibert, Belgium – 26 th January, 2021 – Nyxoah SA (Euronext: NYXH) ...
Everyday Health on MSN
Nerve stimulation for obstructive sleep apnea
If continuous positive airway pressure therapy isn’t working for your sleep apnea, nerve stimulation may be a game changer. Explore how this technology works, the latest devices, and what to expect ...
Mont-Saint-Guibert, Belgium – April 8, 2025, 07:00am CET / 1:00am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), which develops breakthrough treatment alternatives for ...
The Genio system is now available in the US for OSA patients who meet eligibility criteria. The Food and Drug Administration (FDA) has approved the Genio ® system for the treatment of patients with ...
Mont-Saint-Guibert, Belgium – March 26, 2025, 8:00am CET / 3:00am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), that develops breakthrough treatment alternatives for ...
(RTTNews) - Nyxoah SA (NYXH), a medical technology company specializing in innovative treatments for Obstructive Sleep Apnea (OSA), announced the successful implantation of its Genio system in the ...
Assignment to New Technology APC 1580 is positive news for Nyxoah’s U.S. commercial rollout by strengthening hospital and ASC economics Mont-Saint-Guibert, Belgium – November 26, 2025, 7:45 am CET / 1 ...
Nyxoah receives FDA approval for full-body 1.5T and 3T MRI compatibility for the Genio® system to treat Obstructive Sleep Apnea (OSA) Mont-Saint-Guibert, Belgium – 9 th February 2021 – Nyxoah SA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results